The high CXCL10 expression in nontreated tumors implied that CXCL10 may have functions other than T cell recruitment, which could be the opposite.43 Hence, CXCL9 emerged as a potential biomarker of tumor immune recognition and T cell engraftment, which need further clinical verification. This evidence concerns the gene CXCL10 and neoplasm.